70 Gy or more: which dose for which prostate cancer?
- 11 May 2005
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 131 (7) , 407-419
- https://doi.org/10.1007/s00432-005-0681-0
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02Journal of Clinical Oncology, 2003
- Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413Journal of Clinical Oncology, 2003
- Dose response in prostate cancer with 8–12 years’ follow-upInternational Journal of Radiation Oncology*Biology*Physics, 2002
- LATE NORMAL TISSUE SEQUELAE IN THE SECOND DECADE AFTER HIGH DOSE RADIATION THERAPY WITH COMBINED PHOTONS AND CONFORMAL PROTONS FOR LOCALLY ADVANCED PROSTATE CANCERJournal of Urology, 2002
- HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Radiation dose response in patients with favorable localized prostate cancer (Stage T1–T2, biopsy Gleason ≤ 6, and pretreatment prostate-specific antigen ≤ 10)International Journal of Radiation Oncology*Biology*Physics, 2001
- A CATALOG OF PROSTATE CANCER NOMOGRAMSJournal of Urology, 2001
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patientsUrology, 1995
- Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinomaUrology, 1987